V6 Anti-Human MAPT (Zagotenemab)
Product Specifications
Expression System
CHO
Reactivity
Human
Target
MAPT
Purification
Protein A
Endotoxin
<1EU/mg Determined by LAL gel clotting assay
Purity
>95% Determined by SDS-PAGE
Buffer
ABDB-1002 or PBS, pH 7.4, Contains no stabilizers or preservatives.
Storage Conditions
The product need to be stored at the original stock concentration at 4°C.Avoid freeze / thaw cycle.
Formulation
PBS, pH 7.4, Contains no stabilizers or preservatives
Sterility
0.2 μM filtered
Isotype
Human IgG4 (S228P/F234A/L235A/K447Del) -kappa
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1419108-01 0.5 mg (E-Coli)
Recombinant Human V-set and immunoglobulin domain-containing protein 10-like (VSIG10L), partial
Ask
View Details MBS1419108-02 0.05 mg (Baculovirus)
Recombinant Human V-set and immunoglobulin domain-containing protein 10-like (VSIG10L), partial
Ask
View Details MBS1419108-03 0.5 mg (Yeast)
Recombinant Human V-set and immunoglobulin domain-containing protein 10-like (VSIG10L), partial
Ask
View Details 
MBS1419108-04 0.05 mg (Mammalian-Cell)
Recombinant Human V-set and immunoglobulin domain-containing protein 10-like (VSIG10L), partial
Ask
View Details MBS1419108-05 1 mg (E-Coli)
Recombinant Human V-set and immunoglobulin domain-containing protein 10-like (VSIG10L), partial
Ask
View Details MBS1419108-06 0.1 mg (Baculovirus)
Recombinant Human V-set and immunoglobulin domain-containing protein 10-like (VSIG10L), partial
Ask
View Details